Literature DB >> 11106088

Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia.

K Ohkuma1, M Okada, H Murayama, M Seo, K Maeda, M Kanda, N Okabe.   

Abstract

AIMS: To evaluate the effect of Helicobacter pylori infection and aging on atrophy and intestinal metaplasia of the gastric mucosa.
METHODS: One hundred and sixty-three patients were divided into three age groups and underwent an upper gastrointestinal endoscopy where no esophagitis, peptic ulcers, or malignancies were detected. Two biopsy specimens were obtained from the anterior and posterior walls of the antrum and of the fundus. These were used to evaluate the grade of gastritis, bacterial culture and histologic evidence of H. pylori infection.
RESULTS: Helicobacter pylori infection was found to be directly associated with an increased risk of gastritis grade (odds ratio (OR) = 90 (95% CI; 30-270)). An age of 60 years and older along with H. pylori infection was also strongly associated with an increased risk of atrophy (OR = 6.6, (95% CI; 2.9-15.2)); OR = 9.8, (95% CI; 2.7-35.4)), as was intestinal metaplasia of the gastric mucosa (OR = 5.5, (95% CI; 1.7-17.6)); OR = 7.9, (95% CI; 2.8-46.1)). The prevalence of atrophic gastritis increased with advancing age in H. pylori-infected patients, but no such phenomenon was observed in H. pylori-uninfected patients. The prevalence of intestinal metaplasia significantly increased with advancing age, irrespective of the presence of H. pylori infection. In addition, H. pylori uninfected female patients had a decreased risk of intestinal metaplasia.
CONCLUSIONS: These results suggest that atrophic gastritis is not a normal aging process, but instead is likely to be the result of H. pylori infection, while intestinal metaplasia is caused by both the aging process and H. pylori infection. A decreased risk of intestinal metaplasia found in uninfected female subjects may partly explain the lower prevalence of gastric cancer in females than in males.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11106088     DOI: 10.1046/j.1440-1746.2000.02305.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  20 in total

1.  Assessing the risks and benefits of treating Helicobacter pylori infection.

Authors:  Ivan F N Hung; Benjamin C Y Wong
Journal:  Therap Adv Gastroenterol       Date:  2009-05       Impact factor: 4.409

2.  Influence of various proton pump inhibitors on intestinal metaplasia in noneradicated Helicobacter pylori patients.

Authors:  Marinko Marusic; Zarko Babic; Mirjana Nesanovic; Mira Lucijanic-Mlinac; Vesna Stajcar
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

3.  Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report.

Authors:  P Malfertheiner; F Megraud; C O'Morain; F Bazzoli; E El-Omar; D Graham; R Hunt; T Rokkas; N Vakil; E J Kuipers
Journal:  Gut       Date:  2006-12-14       Impact factor: 23.059

4.  The significance of E266K polymorphism in the NOD1 gene on Helicobacter pylori infection: an effective force on pathogenesis?

Authors:  Banu Kara; Hikmet Akkiz; Figen Doran; Suleyman Bayram; Eren Erken; Yuksel Gumurdullu; Macit Sandikci
Journal:  Clin Exp Med       Date:  2009-10-31       Impact factor: 3.984

5.  Predictive findings for Helicobacter pylori-uninfected, -infected and -eradicated gastric mucosa: validation study.

Authors:  Kazuhiro Watanabe; Naoyoshi Nagata; Ryo Nakashima; Etsuko Furuhata; Takuro Shimbo; Masao Kobayakawa; Toshiyuki Sakurai; Koh Imbe; Ryota Niikura; Chizu Yokoi; Junichi Akiyama; Naomi Uemura
Journal:  World J Gastroenterol       Date:  2013-07-21       Impact factor: 5.742

6.  Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.

Authors:  Pei-Fang Ning; Hui-Jie Liu; Yuan Yuan
Journal:  World J Gastroenterol       Date:  2005-05-07       Impact factor: 5.742

7.  Association between cag-pathogenicity island in Helicobacter pylori isolates from peptic ulcer, gastric carcinoma, and non-ulcer dyspepsia subjects with histological changes.

Authors:  Mahaboob Ali; Aleem A Khan; Santosh K Tiwari; Niyaz Ahmed; L Venkateswar Rao; C-M Habibullah
Journal:  World J Gastroenterol       Date:  2005-11-21       Impact factor: 5.742

8.  Prevalence of Helicobacter pylori seropositivity among patients undergoing bariatric surgery: a preliminary study.

Authors:  Tolga Erim; Marcia R Cruz-Correa; Samuel Szomstein; Evelio Velis; Raul Rosenthal
Journal:  World J Surg       Date:  2008-09       Impact factor: 3.352

9.  Chronic gastritis rat model and role of inducing factors.

Authors:  Zun Xiang; Jian-Min Si; Huai-De Huang
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

10.  Reciprocal impact of host factors and Helicobacter pylori genotypes on gastric diseases.

Authors:  Sahar Honarmand-Jahromy; Farideh Siavoshi; Reza Malekzadeh; Taher Nejad Sattari; Saeid Latifi-Navid
Journal:  World J Gastroenterol       Date:  2015-08-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.